Compare LQDA & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LQDA | BIRK |
|---|---|---|
| Founded | 2004 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.6B |
| IPO Year | 2020 | 2023 |
| Metric | LQDA | BIRK |
|---|---|---|
| Price | $68.49 | $33.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 14 |
| Target Price | $41.00 | ★ $61.43 |
| AVG Volume (30 Days) | 963.9K | ★ 2.0M |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.81 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $158,320,000.00 | N/A |
| Revenue This Year | $278.87 | $13.71 |
| Revenue Next Year | $57.13 | $14.30 |
| P/E Ratio | $56.31 | ★ $17.48 |
| Revenue Growth | ★ 1031.18 | N/A |
| 52 Week Low | $21.35 | $29.93 |
| 52 Week High | $93.61 | $50.73 |
| Indicator | LQDA | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 51.00 |
| Support Level | $62.86 | $33.06 |
| Resistance Level | $92.35 | $37.29 |
| Average True Range (ATR) | 2.78 | 1.08 |
| MACD | 0.69 | 0.44 |
| Stochastic Oscillator | 66.74 | 80.36 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.